Ledger.Open graph →

SEC Form D · Amendment · filed June 16, 2015

Kinex Pharmaceuticals, Inc

Offering

—

Sold

$74.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Buffalo, NY

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Flint Besecker · Buffalo, NYExec · Director Jinn Wu · Buffalo, NYDirector Johnson Lau · Buffalo, NYExec · Director Pamela J. Evans · Cincinnati, OHDirector Terry L. Meadors · Cincinnati, OHExec · Director Mario Garcia · AUSTIN, TXExec · Director Maziyar Yousefizad · Gainesville, FLExec · Director David Darst · New York, NYDirector Thomas Varghese · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗